Diffusion of ketoprofen into the cerebrospinal fluid of young children

Hannu Kokki1, Marko Karvinen, Antti Jekunen

  • 1Department of Anaesthesiology and Intensive Care, Kuopio University Hospital, Kuopio, Finland. hannu.kokki@kuh.fi

Insights

Ketoprofen did not reach measurable levels in cerebrospinal fluid (CSF) in children after a single oral dose. Even with high plasma concentrations, CSF levels remained undetectable, suggesting the dose was too low for therapeutic effect in the central nervous system.

Area of Science:

  • Pharmacokinetics
  • Pediatric Pharmacology
  • Neuroscience

Background:

  • Investigating ketoprofen's entry into the cerebrospinal fluid (CSF) after oral administration.
  • Determining the minimum plasma concentration required for detectable CSF levels.

Purpose of the Study:

  • To assess ketoprofen's penetration into the CSF following a single oral dose of 1 mg/kg in children.
  • To establish the lowest plasma ketoprofen concentration yielding measurable CSF levels.

Main Methods:

  • 10 healthy children (9-86 months) post-spinal anesthesia received a single oral dose of ketoprofen syrup (1 mg/kg).
  • CSF and plasma samples were collected 30 minutes post-administration.
  • Ketoprofen concentrations were quantified using validated high-performance liquid chromatography (HPLC) with a 0.02 µg/mL lower limit of detection.

Main Results:

  • Ketoprofen was detectable in CSF in only one child with the highest plasma concentration (7.4 µg/mL).
  • At plasma concentrations of 6.5 µg/mL or lower, CSF ketoprofen levels were unmeasurable.
  • The observed CSF/plasma ratio was 0.008.

Conclusions:

  • A single oral dose of 1 mg/kg ketoprofen is insufficient to achieve measurable CSF levels within 30 minutes in pediatric patients.
  • The findings suggest limitations in ketoprofen's central nervous system penetration at this dosage.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Physiological Barriers01:25

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...